Skip to content

Clinical trials

Phase 3 Arrhythmias, Cardiac trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arrhythmias, Cardiac Phase: Phase 3 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20041
20062
20071
20081
20111
20121
20132
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated2
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Forest Laboratories3
Janssen Scientific Affairs, LLC2
AtriCure, Inc.1
Biosense Webster, Inc.1
Icahn School of Medicine at Mount Sinai1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
ProRhythm, Inc.1
Regional Hospital of Scranton1
Sanofi1
US Department of Veterans Affairs1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arrhythmias, Cardiac13
Atrial Fibrillation9
Atrial Flutter2
Heart Diseases2
Cardiomyopathy, Dilated1
Cardiovascular Diseases1
Death, Sudden, Cardiac1
Embolism1
Inflammation1
Postoperative Complications1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.